MYNZ
Mainz Biomed NV
Price Chart
No historical data available
Latest Quote
$0.84
+0.02 (+2.71%)
Current Price
| Previous Close | $0.82 |
| Open | $0.80 |
| Day High | $0.86 |
| Day Low | $0.74 |
| Volume | 5,235,144 |
Stock Information
| Shares Outstanding | 12.52M |
| Total Debt | $3.09M |
| Cash Equivalents | $1.91M |
| Revenue | $660K |
| Net Income | $-18.97M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $10.56M |
| EPS (TTM) | $-5.28 |
| Exchange | NGM |
Recent Price History
No history data available. Data will be fetched automatically.
About Mainz Biomed NV
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $319,108 | $385,820 | $123,166 | $368,180 |
| Cost Of Revenue | $319,108 | $385,820 | $347,726 | $399,726 |
| Total Revenue | $893,991 | $895,479 | $529,877 | $577,348 |
| Operating Revenue | $893,991 | $895,479 | $529,877 | $577,348 |
| Expenses | ||||
| Interest Expense | $1,075,232 | $559,581 | $289,324 | $339,171 |
| Total Expenses | $19,312,239 | $27,540,161 | $26,973,917 | $10,301,954 |
| Other Income Expense | $-2,157,183 | $1,158,536 | $346,028 | $-1,626,321 |
| Other Non Operating Income Expenses | $-1,908,351 | $1,109,859 | $346,028 | $393,418 |
| Net Non Operating Interest Income Expense | $-1,075,232 | $-809,581 | $-289,324 | $-339,171 |
| Interest Expense Non Operating | $1,075,232 | $559,581 | $289,324 | $339,171 |
| Operating Expense | $18,993,131 | $27,154,341 | $26,626,191 | $9,902,228 |
| Selling And Marketing Expense | $4,695,285 | $3,803,351 | $5,018,728 | $626,366 |
| General And Administrative Expense | $8,079,637 | $13,418,194 | $16,432,859 | $8,755,545 |
| Total Other Finance Cost | - | $250,000 | - | $139,974 |
| Other Operating Expenses | - | - | $-269,286 | $-350,407 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Net Interest Income | $-1,075,232 | $-809,581 | $-289,324 | $-339,171 |
| Normalized Income | $-21,401,831 | $-26,344,404 | $-26,387,336 | $-9,670,359 |
| Net Income From Continuing And Discontinued Operation | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Total Operating Income As Reported | $-18,695,408 | $-26,644,682 | $-26,444,040 | $-9,724,606 |
| Net Income Common Stockholders | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Net Income | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Net Income Including Noncontrolling Interests | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Net Income Continuous Operations | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Pretax Income | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Special Income Charges | $-248,832 | $48,677 | $0 | $-2,019,739 |
| Operating Income | $-18,418,248 | $-26,644,682 | $-26,444,040 | $-9,724,606 |
| Depreciation Amortization Depletion Income Statement | $379,176 | $342,403 | $155,238 | $38,383 |
| Depreciation And Amortization In Income Statement | $379,176 | $342,403 | $155,238 | $38,383 |
| Gross Profit | $574,883 | $509,659 | $182,151 | $177,622 |
| Depreciation Income Statement | - | - | - | $29,515 |
| Per Share | ||||
| Diluted EPS | $-22.36 | $-64.76 | $-74.55 | $-64.80 |
| Basic EPS | $-22.36 | $-64.76 | $-74.55 | $-64.80 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-19,309,562 | $-24,918,411 | $-25,718,214 | $-9,261,259 |
| Total Unusual Items | $-248,832 | $48,677 | $0 | $-2,019,739 |
| Total Unusual Items Excluding Goodwill | $-248,832 | $48,677 | $0 | $-2,019,739 |
| Reconciled Depreciation | $1,017,037 | $866,412 | $379,798 | $69,929 |
| EBITDA (Bullshit earnings) | $-19,558,394 | $-24,869,734 | $-25,718,214 | $-11,280,998 |
| EBIT | $-20,575,431 | $-25,736,146 | $-26,098,012 | $-11,350,927 |
| Diluted Average Shares | $968,234 | $406,058 | $353,937 | $180,272 |
| Basic Average Shares | $968,234 | $406,058 | $353,937 | $180,272 |
| Diluted NI Availto Com Stockholders | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Business | $28,328 | $0 | $0 | - |
| Write Off | $47,449 | $0 | $0 | $0 |
| Restructuring And Mergern Acquisition | $229,711 | $0 | $0 | $2,019,739 |
| Research And Development | $5,839,033 | $9,590,393 | $5,019,366 | $481,934 |
| Selling General And Administration | $12,774,922 | $17,221,545 | $21,451,587 | $9,381,911 |
| Other Gand A | $3,891,563 | $5,580,524 | $3,820,717 | $1,254,478 |
| Insurance And Claims | $536,546 | $817,181 | $920,121 | $170,464 |
| Salaries And Wages | $3,651,528 | $7,020,489 | $11,692,021 | $7,330,603 |
| Other Special Charges | - | $-48,677 | - | - |
Fetched: 2026-03-10
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,029,081 | $-145,419 | $14,096,067 | $6,361,155 |
| Total Assets | $13,238,167 | $15,409,028 | $20,241,003 | $10,040,795 |
| Total Non Current Assets | $5,394,137 | $6,429,132 | $1,862,662 | $431,586 |
| Goodwill And Other Intangible Assets | $3,017,462 | $3,394,645 | $0 | $0 |
| Current Assets | $7,844,030 | $8,979,896 | $18,378,341 | $9,609,209 |
| Prepaid Assets | $1,021,745 | $940,715 | $801,959 | $769,825 |
| Inventory | $372,870 | $613,638 | $175,469 | $0 |
| Receivables | $213,745 | $354,510 | $259,138 | $111,842 |
| Taxes Receivable | $162,930 | $260,955 | $192,154 | $94,085 |
| Accounts Receivable | $33,577 | $93,555 | $63,736 | $17,199 |
| Allowance For Doubtful Accounts Receivable | $0 | $-28,180 | $-66,852 | $-796 |
| Gross Accounts Receivable | $33,577 | $121,735 | $130,588 | $17,995 |
| Cash Cash Equivalents And Short Term Investments | $6,235,670 | $7,070,925 | $17,141,775 | $8,727,542 |
| Cash And Cash Equivalents | $6,235,670 | $7,070,925 | $17,141,775 | $8,727,542 |
| Cash Financial | $6,235,670 | $7,070,925 | $17,141,775 | $8,727,542 |
| Other Non Current Assets | - | $108 | $23,275 | - |
| Other Current Assets | - | $108 | - | - |
| Other Receivables | - | - | $3,248 | $558 |
| Debt | ||||
| Total Debt | $3,271,381 | $7,420,780 | $3,228,257 | $2,576,394 |
| Long Term Debt And Capital Lease Obligation | $865,982 | $2,195,889 | $1,902,330 | $2,327,885 |
| Current Debt And Capital Lease Obligation | $2,405,399 | $5,224,891 | $1,325,927 | $248,509 |
| Current Debt | $2,125,254 | $4,936,428 | $1,040,573 | $193,433 |
| Other Current Borrowings | $2,125,254 | $4,936,428 | $1,040,573 | $193,433 |
| Long Term Debt | - | $1,030,166 | $943,214 | $1,940,119 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,191,624 | $12,159,802 | $6,144,936 | $3,679,640 |
| Total Non Current Liabilities Net Minority Interest | $1,242,078 | $2,922,866 | $1,902,330 | $2,327,885 |
| Other Non Current Liabilities | $376,096 | $726,977 | - | - |
| Current Liabilities | $5,949,546 | $9,236,936 | $4,242,606 | $1,351,755 |
| Other Current Liabilities | $690,575 | $388,839 | - | - |
| Current Deferred Liabilities | $0 | $138,889 | $199,410 | - |
| Payables And Accrued Expenses | $2,853,572 | $3,484,317 | $2,717,269 | $1,103,246 |
| Payables | $1,812,701 | $2,626,375 | $1,333,044 | $835,735 |
| Accounts Payable | $1,254,187 | $2,326,439 | $1,333,044 | $832,518 |
| Total Tax Payable | - | - | $0 | $3,217 |
| Derivative Product Liabilities | - | - | - | $1,940,119 |
| Other Payable | - | - | - | $233,710 |
| Equity | ||||
| Common Stock Equity | $6,046,543 | $3,249,226 | $14,096,067 | $6,361,155 |
| Total Equity Gross Minority Interest | $6,046,543 | $3,249,226 | $14,096,067 | $6,361,155 |
| Stockholders Equity | $6,046,543 | $3,249,226 | $14,096,067 | $6,361,155 |
| Gains Losses Not Affecting Retained Earnings | $27,038,075 | $20,833,903 | $18,131,923 | $9,738,545 |
| Other Equity Adjustments | $27,038,075 | $20,833,903 | $18,131,923 | $9,738,545 |
| Retained Earnings | $-90,978,684 | $-69,328,021 | $-43,032,294 | $-16,644,958 |
| Other | ||||
| Ordinary Shares Number | $2,319,353 | $529,137 | $365,736 | $300,250 |
| Share Issued | $2,319,353 | $529,137 | $365,736 | $300,250 |
| Tangible Book Value | $3,029,081 | $-145,419 | $14,096,067 | $6,361,155 |
| Invested Capital | $8,171,797 | $9,215,820 | $16,079,854 | $8,494,707 |
| Working Capital | $1,894,484 | $-257,040 | $14,135,735 | $8,257,454 |
| Capital Lease Obligations | $1,146,127 | $1,454,186 | $1,244,470 | $442,842 |
| Total Capitalization | $6,046,543 | $4,279,392 | $15,039,281 | $8,301,274 |
| Additional Paid In Capital | $69,065,027 | $51,507,526 | $38,831,542 | $13,126,493 |
| Capital Stock | $922,125 | $235,818 | $164,896 | $141,075 |
| Common Stock | $922,125 | $235,818 | $164,896 | $141,075 |
| Long Term Capital Lease Obligation | $865,982 | $1,165,723 | $959,116 | $387,766 |
| Current Deferred Revenue | $0 | $138,889 | $199,410 | - |
| Current Capital Lease Obligation | $280,145 | $288,463 | $285,354 | $55,076 |
| Current Accrued Expenses | $1,040,871 | $857,942 | $1,384,225 | $267,511 |
| Dueto Related Parties Current | $558,514 | $299,936 | - | - |
| Net PPE | $2,376,675 | $3,034,487 | $1,839,387 | $431,586 |
| Accumulated Depreciation | $-1,345,689 | $-895,097 | $-472,535 | $-218,775 |
| Gross PPE | $3,722,364 | $3,929,584 | $2,311,922 | $650,361 |
| Construction In Progress | $0 | $59,929 | $0 | - |
| Other Properties | $1,505,887 | $1,588,794 | $942,141 | $100,767 |
| Machinery Furniture Equipment | $612,376 | $616,224 | $334,581 | $60,451 |
| Buildings And Improvements | $1,604,101 | $1,664,637 | $1,035,200 | $489,143 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-25,059 | $-56,833 | $0 | - |
| Finished Goods | $84,253 | $240,467 | $0 | - |
| Raw Materials | $313,676 | $430,004 | $175,469 | - |
| Duefrom Related Parties Current | $17,238 | $0 | - | - |
| Leases | - | - | - | $489,143 |
Fetched: 2026-03-10
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-17,344,960 | $-23,837,686 | $-15,428,073 | $-3,237,029 |
| Operating Activities | ||||
| Operating Cash Flow | $-17,090,011 | $-21,938,845 | $-14,769,590 | $-3,220,324 |
| Cash Flow From Continuing Operating Activities | $-17,090,011 | $-21,938,845 | $-14,769,590 | $-3,220,324 |
| Operating Gains Losses | $-75,147 | $-48,677 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-254,949 | $-1,898,841 | $-658,483 | $-16,705 |
| Investing Cash Flow | $-198,817 | $-1,898,841 | $-658,483 | $1,203,151 |
| Cash Flow From Continuing Investing Activities | $-198,817 | $-1,898,841 | $-658,483 | $1,203,151 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $13,764,717 | $6,392,751 | $23,865,889 | $10,425,160 |
| Financing Cash Flow | $16,599,629 | $14,226,692 | $23,943,418 | $10,610,534 |
| Cash Flow From Continuing Financing Activities | $16,599,629 | $14,226,692 | $23,943,418 | $10,610,534 |
| Net Common Stock Issuance | $13,764,717 | $6,392,751 | $23,865,889 | $10,425,160 |
| Common Stock Issuance | $13,764,717 | $6,392,751 | $23,865,889 | $10,425,160 |
| Other | ||||
| Repayment Of Debt | $-1,475,088 | $-2,286,059 | $-304,971 | $-61,240 |
| Issuance Of Debt | $4,310,000 | $10,120,000 | $0 | $246,614 |
| Interest Paid Supplemental Data | $198,061 | $153,580 | $125,543 | $46,240 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | - |
| End Cash Position | $6,235,670 | $7,070,925 | $17,141,775 | $8,727,542 |
| Beginning Cash Position | $7,070,925 | $17,141,775 | $8,727,542 | $122,568 |
| Effect Of Exchange Rate Changes | $-146,056 | $-459,856 | $-101,112 | $11,613 |
| Changes In Cash | $-689,199 | $-9,610,994 | $8,515,345 | $8,593,361 |
| Proceeds From Stock Option Exercised | $0 | $0 | $382,500 | $0 |
| Net Issuance Payments Of Debt | $2,834,912 | $7,833,941 | $-304,971 | $185,374 |
| Net Short Term Debt Issuance | $3,130,167 | $9,020,000 | $0 | $7,673 |
| Short Term Debt Payments | $-1,179,833 | $-1,100,000 | $0 | $0 |
| Short Term Debt Issuance | $4,310,000 | $10,120,000 | $0 | $7,673 |
| Net Long Term Debt Issuance | $-295,255 | $-1,186,059 | $-304,971 | $177,701 |
| Long Term Debt Payments | $-295,255 | $-1,186,059 | $-304,971 | $-61,240 |
| Net Business Purchase And Sale | $32,785 | $0 | $0 | $1,219,856 |
| Sale Of Business | $32,785 | $0 | $0 | $1,219,856 |
| Net Intangibles Purchase And Sale | $-150,000 | $-700,000 | $0 | - |
| Purchase Of Intangibles | $-150,000 | $-700,000 | $0 | - |
| Net PPE Purchase And Sale | $-81,602 | $-1,198,841 | $-658,483 | $-16,705 |
| Sale Of PPE | $23,347 | $0 | $0 | - |
| Purchase Of PPE | $-104,949 | $-1,198,841 | $-658,483 | $-16,705 |
| Change In Working Capital | $51,746 | $-64,630 | $1,387,006 | $-138,616 |
| Change In Other Working Capital | $-135,724 | $-60,521 | $173,902 | $11,080 |
| Change In Payables And Accrued Expense | $84,610 | $720,237 | $1,650,500 | $659,645 |
| Change In Prepaid Assets | $8,771 | $-239,703 | $-53,788 | $-833,556 |
| Change In Inventory | $29,811 | $-500,187 | $-172,377 | $0 |
| Change In Receivables | $64,278 | $15,544 | $-211,231 | $24,215 |
| Other Non Cash Items | $156,717 | $168,109 | $-38,604 | $2,108,303 |
| Stock Based Compensation | $1,136,430 | $4,005,629 | $9,824,157 | $6,430,158 |
| Unrealized Gain Loss On Investment Securities | $2,052,000 | $-661,000 | $0 | $0 |
| Asset Impairment Charge | $221,869 | $91,039 | $65,389 | $0 |
| Depreciation Amortization Depletion | $1,017,037 | $866,412 | $379,798 | $69,929 |
| Depreciation And Amortization | $1,017,037 | $866,412 | $379,798 | $69,929 |
| Gain Loss On Sale Of PPE | $-46,818 | $0 | $0 | - |
| Gain Loss On Sale Of Business | $-28,329 | $0 | $0 | - |
| Net Income From Continuing Operations | $-21,650,663 | $-26,295,727 | $-26,387,336 | $-11,690,098 |
| Long Term Debt Issuance | - | $0 | $0 | $238,941 |
| Changes In Account Receivables | - | - | - | $24,215 |
Fetched: 2026-03-10